|
Hypophysitis
|
C10.228.140.617.738.275 |
|
|
DNA-Activated Protein Kinase
|
D12.776.157.687.438 |
|
|
Poly-ADP-Ribose Binding Proteins
|
D12.776.157.687 |
|
|
Factor XIa
|
D015945 |
[Activated form of factor XI. In the intrinsic pathway, Factor XI is activated to XIa by factor XIIa in the presence of cofactor HMWK; (HIGH MOLECULAR WEIGHT KININOGEN). Factor XIa then activates factor IX to factor IXa in the presence of calcium.
] |
|
Macrophage Inflammatory Proteins
|
D23.529.374.200.600 |
|
|
Cochlear Nerve
|
A08.800.800.120.910.120 |
|
|
Reticulocytosis
|
C23.888.760 |
|
|
Ethylene Dibromide
|
D015946 |
[An effective soil fumigant, insecticide, and nematocide. In humans, it causes severe burning of skin and irritation of the eyes and respiratory tract. Prolonged inhalation may cause liver necrosis. It is also used in gasoline. Members of this group have caused liver and lung cancers in rodents. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), 1,2-dibromoethane may reasonably be anticipated to be a carcinogen.
] |
|
Factor Va
|
D015943 |
[Activated form of factor V. It is an essential cofactor for the activation of prothrombin catalyzed by factor Xa.
] |
|
Mustard Plant
|
B01.650.940.800.575.912.250.157.200.500 |
|
|
Factor VIIIa
|
D015944 |
[Activated form of factor VIII. The B-domain of factor VIII is proteolytically cleaved by thrombin to form factor VIIIa. Factor VIIIa exists as a non-covalent dimer in a metal-linked (probably calcium) complex and functions as a cofactor in the enzymatic activation of factor X by factor IXa. Factor VIIIa is similar in structure and generation to factor Va.
] |
|
Factor IXa
|
D015949 |
[Activated form of factor IX. This activation can take place via the intrinsic pathway of blood coagulation by the action of factor XIa and calcium, or via the extrinsic pathway by the action of factor VIIa, thromboplastin, and calcium. Factor IXa serves to activate factor X to Xa by cleaving the arginyl-leucine peptide bond in factor X.
] |
|
Keratoplasty, Penetrating
|
D015948 |
[Partial or total replacement of all layers of a central portion of the cornea.
] |
|
Conservative Treatment
|
D000072700 |
[Therapeutic approaches that are limited, gradual, or well-established as opposed to radical methods.
] |
|
Shared Governance, Nursing
|
N02.360.740.523.500 |
|
|
Drug Resistance, Viral
|
G06.920.225 |
|
|
Complement Hemolytic Activity Assay
|
D015941 |
[A screening assay for circulating COMPLEMENT PROTEINS. Diluted SERUM samples are added to antibody-coated ERYTHROCYTES and the percentage of cell lysis is measured. The values are expressed by the so called CH50, in HEMOLYTIC COMPLEMENT units per milliliter, which is the dilution of serum required to lyse 50 percent of the erythrocytes in the assay.
] |
|
Factor VIIa
|
D015942 |
[Activated form of factor VII. Factor VIIa activates factor X in the extrinsic pathway of blood coagulation.
] |
|
Physical Conditioning, Human
|
G11.427.410.698.277.311 |
|
|
Immersion Foot
|
C17.800.321.500 |
|
